The article warns that AI is rapidly becoming a gatekeeper in prior authorization, with algorithms increasingly making or influencing medication approval decisions that can affect patient access to care. While payers promote AI as an efficiency tool, critics argue that opaque automated denials could amplify existing biases, undermine physician judgment, and worsen clinician burnout. The author calls for stronger safeguards—including explainable decisions, human oversight, equity audits, clinician involvement, and patient transparency—to ensure AI improves access rather than becoming a barrier between patients and needed treatment.
Author: Abhay Panchal
A bipartisan Medicare reform effort is gaining momentum in Congress, with lawmakers advancing legislation aimed at fixing the budget-neutrality rules that have contributed to years of physician payment cuts. The proposed Provider Reimbursement Stability Act would raise the threshold that triggers payment reductions, update cost calculations more regularly, and limit annual swings in Medicare’s physician conversion factor. The push comes as physicians face uncertainty over the future of a temporary 2.5% Medicare pay increase for 2026, which expires at the end of the year. Physician groups argue that Medicare reimbursement has failed to keep pace with inflation and rising practice…
The U.S. Department of Justice announced a $30 million settlement with Advanced Pathology Solutions and its owners over allegations of kickbacks to gastroenterology practices and medically unnecessary pathology testing. The case centered on a “lean lab” model in which GI practices allegedly received benefits in exchange for exclusively referring pathology specimens to APS, as well as the routine ordering of special stains and confirmatory tests before pathologist review. The settlement highlights ongoing federal scrutiny of pathology referral arrangements and utilization practices. In addition to the financial penalty, APS entered into a five-year Corporate Integrity Agreement requiring enhanced compliance oversight, auditing,…
Researchers at MIT, SMART, and collaborators developed the first fluorescent nanosensor capable of rapidly detecting indole-3-propionic acid (IPA), a gut microbiome metabolite linked to inflammation, IBD, diabetes, and liver disease. Unlike traditional mass spectrometry, the sensor delivers results within minutes and successfully distinguished healthy individuals from IBD patients in testing on 125 human plasma samples. The technology could enable faster, more accessible gut health monitoring, point-of-care diagnostics, wearable sensors, and personalized nutrition or therapeutic tracking, potentially bringing real-time microbiome function assessment into clinical practice.
Key Takeaways Automated text reminders were associated with a 9.0-percentage-point higher FIT completion rate than nurse-led telephone outreach in a randomized quality improvement trial of automated text reminders for FIT completion. The comparison took place across eight federally qualified health centers in Brooklyn, New York. Adults with a new FIT order received automated one-way text reminders or a nurse-led reminder call after the order was placed.
Most patients who undergo a combined upper and lower GI endoscopy think of it as one procedure. In clinical terms, it is two: an esophagogastroduodenoscopy examining the upper tract, followed by a colonoscopy examining the lower. The appeal of doing both in a single session is obvious. One preparation, one sedation event, and less time away from work or family. For health systems managing a specialist shortage that is projected to reach nearly 1,400 gastroenterologists by 2037, consolidating procedures wherever possible is moving from a convenience to a strategic necessity. But combined GI endoscopy is rarely framed as a deliberate…
Channel Robotics has raised $2.5 million in Seed+ funding, bringing its total funding to $4.6 million, to advance a handheld AI-enabled endoscopic robotic platform designed to work through existing flexible endoscopes. Unlike large robotic systems that require significant capital investment, the company’s approach aims to deliver robotic-level dexterity in a handheld format that could be adopted across hospitals, ASCs, and community GI practices. The funding will support product development, manufacturing, and regulatory activities, with an FDA submission targeted for 2027, reflecting continued investment in next-generation robotic technologies for minimally invasive GI procedures.
Gastroenterologists perform more procedures per physician than nearly any other specialty, and the volume carries risk. Colonoscopy remains the most litigated procedure in GI, but the landscape extends to ERCP (endoscopic retrograde cholangiopancreatography), missed diagnoses and wrong-patient errors. Here are five numbers that define where GI malpractice exposure stands: 0.34% to 2.5%: Rates of serious injury due to colonoscopies vary in research between 0.34% and 2.5%, according to a law firm Miller and Zois analysis. The risk of bowel perforation specifically is estimated at 0.2% to 1%. Perforation is the most litigated injury, but hemorrhage following polyp removal, splenic injury…
Researchers at Northwestern Medicine Digestive Health Center are building evidence that behavioral health interventions can play a critical role in managing GI disorders by targeting the gut-brain axis, hypervigilance, and symptom-specific anxiety. Studies from the group found that patients with conditions such as achalasia, GERD, IBS, Crohn’s disease, and colitis who experience higher levels of anxiety and symptom hypervigilance often report worse outcomes and lower quality of life, even after successful medical or surgical treatment. Researchers are now evaluating cognitive behavioral therapy and other gut-brain interventions to determine whether addressing these psychological factors can improve symptoms, reduce healthcare utilization, and…
The white paper spurred widespread adoption of the POWER program by academic and private gastroenterology and hepatology practices, many of which have used it as a guide for implementing a multidisciplinary obesity care model.2 The aim of this commentary is to provide a comprehensive update of POWER in light of several important developments in the fields of obesity and cardiometabolic diseases in recent years, including the following: